Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;81(3):589-95.
doi: 10.1086/520770. Epub 2007 Jul 24.

Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway

Affiliations

Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway

Ginat Narkis et al. Am J Hum Genet. 2007 Sep.

Abstract

Lethal congenital contractural syndrome type 2 (LCCS2) is an autosomal recessive neurogenic form of arthrogryposis that is associated with atrophy of the anterior horn of the spinal cord. We previously mapped LCCS2 to 6.4 Mb on chromosome 12q13 and have now narrowed the locus to 4.6 Mb. We show that the disease is caused by aberrant splicing of ERBB3, which leads to a predicted truncated protein. ERBB3 (Her3), an activator of the phosphatidylinositol-3-kinase/Akt pathway--regulating cell survival and vesicle trafficking--is essential for the generation of precursors of Schwann cells that normally accompany peripheral axons of motor neurons. Gain-of-function mutations in members of the epidermal growth-factor tyrosine kinase-receptor family have been associated with predilection to cancer. This is the first report of a human phenotype resulting from loss of function of a member of this group.

PubMed Disclaimer

Figures

Figure  1.
Figure 1.
Israeli-Bedouin kindreds affected with LCCS2. Blackened and unblackened symbols represent affected and unaffected individuals, respectively. The numbers denote individuals whose DNA samples were analyzed. A, Pedigree of family A. B, Pedigree of family B.
Figure  2.
Figure 2.
Linkage results for chromosome 12 of two nuclear families of family A. The haplotype showing the homozygosity region is boxed. The arrow indicates a crossing-over event. The lower boundary was determined on the basis of analysis of individual 61.
Figure  3.
Figure 3.
Sequence analysis of the ERBB3 gene in an LCCS2-affected individual. A, Homozygosity for the G→A substitution in intron 10 (affected individual 61). B, Insertion (8 bp) in the cDNA sequence at position 1183 of the ERBB3 gene. chr = Chromosome; ex = exon. C, Schematic representation of the chromosomal locus, the genomic DNA of ERBB3, and the IVS10-8A→G mutation. D, The splice variation occurring in affected individuals. E, Schematic illustration of the protein structure of ErbB3 (according to InterPro) and the predicted mutant truncated protein (395FS399Stop). RLD = Recep_L_domain; FU = Furin-like domain.
Figure  4.
Figure 4.
Splice-site prediction with use of the Neural Networks Splice Site Prediction software (Berkeley Drosophila Genome Project). An alternative additional acceptor splice site was predicted for the ERBB3-mutated sequence.

Similar articles

Cited by

References

Web Resources

    1. Berkeley Drosophila Genome Project, http://www.fruitfly.org/seq_tools/splice-instrucs.html (for the Neural Networks Splice Site Prediction software)
    1. BLAST, http://www.ncbi.nlm.nih.gov/blast/
    1. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (forERBB3 [accession number NM_001982])
    1. InterPro, http://www.ebi.ac.uk/interpro/ (for the EMBL-EBI ERBB3 protein structure)
    1. Map Viewer, http://www.ncbi.nlm.nih.gov/mapview (for build 36)

References

    1. Narkis G, Landau D, Manor E, Elbedour K, Tzemach A, Fishelson M, Geiger D, Ofir R, Carmi R, Birk OS (2004) Homozygosity mapping of lethal congenital contractural syndrome type 2 (LCCS2) to a 6 cM interval on chromosome 12q13. Am J Med Genet A 130:272–27610.1002/ajmg.a.30266 - DOI - PubMed
    1. Landau D, Mishori-Dery A, Hershkovitz R, Narkis G, Elbedour K, Carmi R (2003) A new autosomal recessive congenital contractural syndrome in an Israeli Bedouin kindred. Am J Med Genet A 117:37–4010.1002/ajmg.a.10894 - DOI - PubMed
    1. Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN, McKiernan PJ, Klomp LW, Morris AA, Wraith JE, et al (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet 36:400–40410.1038/ng1325 - DOI - PubMed
    1. Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C, Abdelhaleem M, Hayes JA, Williams MD, Chitayat D, et al (2005) Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis. Blood 106:4159–416610.1182/blood-2005-04-1356 - DOI - PubMed
    1. Carim L, Sumoy L, Andreu N, Estivill X, Escarceller M (2000) Cloning, mapping and expression analysis of VPS33B, the human orthologue of rat Vps33b. Cytogenet Cell Genet 89:92–9510.1159/000015571 - DOI - PubMed

Publication types

Substances

Associated data